BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 26568165)

  • 1. Hepatitis B virus genotype, mutations, human leukocyte antigen polymorphisms and their interactions in hepatocellular carcinoma: a multi-centre case-control study.
    Wen J; Song C; Jiang D; Jin T; Dai J; Zhu L; An J; Liu Y; Ma S; Qin N; Liang C; Chen J; Jiang Y; Yang L; Liu J; Liu L; Geng T; Chen C; Jiang J; Chen J; Zhu F; Zhu Y; Yu L; Shen H; Zhai X; Xu J; Hu Z
    Sci Rep; 2015 Nov; 5():16489. PubMed ID: 26568165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development.
    Hu L; Zhai X; Liu J; Chu M; Pan S; Jiang J; Zhang Y; Wang H; Chen J; Shen H; Hu Z
    Hepatology; 2012 May; 55(5):1426-31. PubMed ID: 22105689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-DR genetic polymorphisms and hepatitis B virus mutations affect the risk of hepatocellular carcinoma in Han Chinese population.
    Zhao Y; Chen K; Yang H; Zhang F; Ding L; Liu Y; Zhang L; Zhang Y; Wang H; Deng Y
    Virol J; 2023 Nov; 20(1):283. PubMed ID: 38037048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptome-wide association study for persistent hepatitis B virus infection and related hepatocellular carcinoma.
    Han J; Chen C; Wang C; Qin N; Huang M; Ma Z; Zhu M; Dai J; Jiang Y; Ma H; Jin G; Shen H; Hu Z
    Liver Int; 2020 Sep; 40(9):2117-2127. PubMed ID: 32574393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variations in STAT4,C2,HLA-DRB1 and HLA-DQ associated with risk of hepatitis B virus-related liver cirrhosis.
    Jiang DK; Ma XP; Wu X; Peng L; Yin J; Dan Y; Huang HX; Ding DL; Zhang LY; Shi Z; Zhang P; Yu H; Sun J; Lilly Zheng S; Deng G; Xu J; Liu Y; Guo J; Cao G; Yu L
    Sci Rep; 2015 Nov; 5():16278. PubMed ID: 26538132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus genotypes, expression quantitative trait loci for ZNRD1-AS1 and their interactions in hepatocellular carcinoma.
    Liu Z; Song C; Wen J; Xu L; Liu Y; Zhu J; Zhu L; Hu Z; Ma H; Liu L
    Oncotarget; 2016 Jul; 7(28):44076-44083. PubMed ID: 27286450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
    Han Y; Pu R; Han X; Zhao J; Li W; Yin J; Zhang Y; Shen Q; Xie J; Zhang Q; Jiang S; Li J; Zhang H; Wang H; Cao G
    Liver Int; 2014 May; 34(5):728-36. PubMed ID: 24118778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriers.
    Li S; Qian J; Yang Y; Zhao W; Dai J; Bei JX; Foo JN; McLaren PJ; Li Z; Yang J; Shen F; Liu L; Yang J; Li S; Pan S; Wang Y; Li W; Zhai X; Zhou B; Shi L; Chen X; Chu M; Yan Y; Wang J; Cheng S; Shen J; Jia W; Liu J; Yang J; Wen Z; Li A; Zhang Y; Zhang G; Luo X; Qin H; Chen M; Wang H; Jin L; Lin D; Shen H; He L; de Bakker PI; Wang H; Zeng YX; Wu M; Hu Z; Shi Y; Liu J; Zhou W
    PLoS Genet; 2012; 8(7):e1002791. PubMed ID: 22807686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus persistent infection-related single nucleotide polymorphisms in HLA regions are associated with viral load in hepatoma families.
    Hsieh AR; Fann CSJ; Lin HC; Tai J; Hsieh SY; Tai DI
    World J Gastroenterol; 2021 Oct; 27(37):6262-6276. PubMed ID: 34712031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of functional nuclear factor-kappaB genetic polymorphisms on hepatitis B virus persistence and their interactions with viral mutations on the risk of hepatocellular carcinoma.
    Zhang Q; Ji XW; Hou XM; Lu FM; Du Y; Yin JH; Sun XY; Deng Y; Zhao J; Han X; Yang GS; Zhang HW; Chen XM; Shen HB; Wang HY; Cao GW
    Ann Oncol; 2014 Dec; 25(12):2413-2419. PubMed ID: 25223483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma.
    Jiang DK; Sun J; Cao G; Liu Y; Lin D; Gao YZ; Ren WH; Long XD; Zhang H; Ma XP; Wang Z; Jiang W; Chen TY; Gao Y; Sun LD; Long JR; Huang HX; Wang D; Yu H; Zhang P; Tang LS; Peng B; Cai H; Liu TT; Zhou P; Liu F; Lin X; Tao S; Wan B; Sai-Yin HX; Qin LX; Yin J; Liu L; Wu C; Pei Y; Zhou YF; Zhai Y; Lu PX; Tan A; Zuo XB; Fan J; Chang J; Gu X; Wang NJ; Li Y; Liu YK; Zhai K; Zhang H; Hu Z; Liu J; Yi Q; Xiang Y; Shi R; Ding Q; Zheng W; Shu XO; Mo Z; Shugart YY; Zhang XJ; Zhou G; Shen H; Zheng SL; Xu J; Yu L
    Nat Genet; 2013 Jan; 45(1):72-5. PubMed ID: 23242368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinoma.
    Sawai H; Nishida N; Khor SS; Honda M; Sugiyama M; Baba N; Yamada K; Sawada N; Tsugane S; Koike K; Kondo Y; Yatsuhashi H; Nagaoka S; Taketomi A; Fukai M; Kurosaki M; Izumi N; Kang JH; Murata K; Hino K; Nishina S; Matsumoto A; Tanaka E; Sakamoto N; Ogawa K; Yamamoto K; Tamori A; Yokosuka O; Kanda T; Sakaida I; Itoh Y; Eguchi Y; Oeda S; Mochida S; Yuen MF; Seto WK; Poovorawan Y; Posuwan N; Mizokami M; Tokunaga K
    Sci Rep; 2018 May; 8(1):7958. PubMed ID: 29784950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replication of genome wide association studies on hepatocellular carcinoma susceptibility loci of STAT4 and HLA-DQ in a Korean population.
    Kim LH; Cheong HS; Namgoong S; Kim JO; Kim JH; Park BL; Cho SW; Park NH; Cheong JY; Koh I; Shin HD; Kim YJ
    Infect Genet Evol; 2015 Jul; 33():72-6. PubMed ID: 25913043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Locus 5p13.1 may be associated with the selection of cancer-related HBV core promoter mutations.
    Chen QY; Hu YL; Wang XY; Harrison TJ; Wang C; Hu LP; Yang QL; Ren CC; Jia HH; Fang AZ
    Int J Med Sci; 2019; 16(7):990-997. PubMed ID: 31341412
    [No Abstract]   [Full Text] [Related]  

  • 16. Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population.
    Kummee P; Tangkijvanich P; Poovorawan Y; Hirankarn N
    J Viral Hepat; 2007 Dec; 14(12):841-8. PubMed ID: 18070287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host genetic variants influencing the clinical course of hepatitis B virus infection.
    Matsuura K; Isogawa M; Tanaka Y
    J Med Virol; 2016 Mar; 88(3):371-9. PubMed ID: 26255971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of PNPLA3, TM6SF2 gene polymorphisms and its interactions with smoking and alcohol drinking on hepatitis B virus-associated hepatocellular carcinoma].
    Wang LQ; Guo WH; Guo ZW; Qin P; Zhang R; Zhu XM; Liu DW
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Dec; 39(12):1611-1616. PubMed ID: 30572387
    [No Abstract]   [Full Text] [Related]  

  • 19. UBE2L3, a susceptibility gene that plays oncogenic role in hepatitis B-related hepatocellular carcinoma.
    Liu Y; Song C; Ni H; Jiao W; Gan W; Dong X; Liu J; Zhu L; Zhai X; Hu Z; Li J
    J Viral Hepat; 2018 Nov; 25(11):1363-1371. PubMed ID: 29969176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of pri-miR-34b/c and pre-miR-196a2 polymorphisms and their multiplicative interactions with hepatitis B virus mutations with hepatocellular carcinoma risk.
    Han Y; Pu R; Han X; Zhao J; Zhang Y; Zhang Q; Yin J; Xie J; Shen Q; Deng Y; Ding Y; Li W; Li J; Zhang H; Cao G
    PLoS One; 2013; 8(3):e58564. PubMed ID: 23516510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.